Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...
Nasdaq

Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes

EDINBURGH, Scotland--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in ...
Barchart on MSN

DexCom’s quarterly earnings preview: What you need to know

San Diego, California-based DexCom, Inc. (DXCM) is a medical technology company focused on continuous glucose monitoring (CGM ...
sharewise

Here's Why You Should Add DexCom Stock to Your Portfolio Now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
StockStory.org on MSN

3 reasons investors love DexCom (DXCM)

Over the last six months, DexCom’s shares have sunk to $62.07, producing a disappointing 6.4% loss - a stark contrast to the ...
The Motley Fool

1 Reason to Sell DexCom Stock, and 1 Reason to Buy

Progress in medicine could lead to a smaller target market for DexCom. However, the company is expanding opportunities through innovation. On the other hand, DexCom has attractive opportunities that ...
Seeking Alpha

Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy

DexCom is expected to remain an outperformer in the healthcare sector in 2024, driven by M&A activity and the growth of GLP-1 weight loss drugs. The company's continuous glucose monitoring ("CGM") ...
AOL

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...